UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic factors for patients with anal cancer treated with conformal radiotherapy-a systematic review

BMC cancer, 2022-06, Vol.22 (1), p.607-12, Article 607

2022

Volltextzugriff (PDF)

Choice of a patient-reported outcome measure for patients with anal cancer for use in cancer clinical trials and routine clinical practice: a mixed methods approach

The Lancet (British edition), 2015-02, Vol.385, p.S38-S38

2015

Volltextzugriff (PDF)

Prognostic factors for recurrence and survival in anal cancer

Cancer, 2013-02, Vol.119 (4), p.748-755

2013

Volltextzugriff (PDF)

Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer – A multicentre dose planning study

Technical innovations & patient support in radiation oncology, 2019-09, Vol.11, p.14-21

2019

Volltextzugriff (PDF)

Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes

British journal of surgery, 2013-07, Vol.100 (8), p.1009-1014

2013

Volltextzugriff (PDF)

Treatment of T4 tumours: the role of radiotherapy

Colorectal disease, 2003-09, Vol.5 (5), p.432-435

Sebag-Montefiore, David

2003

Volltextzugriff (PDF)

Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictors

EBioMedicine, 2024-08, Vol.106, p.105228, Article 105228

2024

Volltextzugriff (PDF)

1294: A Multi-Omics Database Using Clinical Trial Data for Rectal Cancer Radiotherapy Outcome Prediction

Radiotherapy and oncology, 2024-05, Vol.194, p.S4463-S4466

2024

Volltextzugriff (PDF)

1317: Identifying Lymphocyte Infiltration for Rectal Cancer Outcome Prediction Using Phase III Trial Data

Radiotherapy and oncology, 2024-05, Vol.194, p.S4466-S4470

2024

Volltextzugriff (PDF)

STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3502-3502

2022

Volltextzugriff (PDF)

“Global Multidisciplinary Team Meetings”: Challenging Cases Virtual Forums from the International Multidisciplinary Anal Cancer Conference (IMACC)

Clinical colorectal cancer, 2022-09, Vol.21 (3), p.175-187

2022

Volltextzugriff (PDF)

Abstract LB129: Stratification of radiotherapy and fluoropyrimidine-based chemotherapy from multi-omic profiling in rectal cancer biopsies

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB129-LB129

2021

Volltextzugriff (PDF)

Radiotherapy for rectal cancer: Short course versus long course – When and how

European journal of cancer supplements, 2013-09, Vol.11 (2), p.282-283

Sebag-Montefiore, David

2013

Volltextzugriff (PDF)

153 - CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S69-S70

2022

Volltextzugriff (PDF)

CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S69-S70

2022

Volltextzugriff (PDF)

SPARC: A phase-I trial of pre-operative margin-intensified stereotactic radiotherapy for pancreatic cancer at high risk of positive resection margins

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.TPS536-TPS536

2018

Volltextzugriff (PDF)

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4101-4101

2020

Volltextzugriff (PDF)

Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.373-373

2020

Volltextzugriff (PDF)

Radical surgery versus organ preservation for early-stage rectal cancer – Authors' reply

The lancet. Gastroenterology & hepatology, 2021-04, Vol.6 (4), p.263-264

2021

Volltextzugriff (PDF)

Compliance to chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA) according to radiotherapy (RT) dose, overall treatment time (OTT) and chemotherapy (CT) and their impact on long-term outcome: Results of ACT II

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.3518-3518

2015

Volltextzugriff (PDF)

Short-course radiotherapy followed by neo-adjuvant chemotherapy in rectal cancer with synchronous liver metastases: A single institution experience

European journal of surgical oncology, 2016-11, Vol.42 (11), p.S232-S232

2016

Volltextzugriff (PDF)

Is there a role for palliative pelvic radiotherapy in pelvic symptom control in metastatic/unresectable rectal cancer?

European journal of surgical oncology, 2016-11, Vol.42 (11), p.S232-S232

2016

Volltextzugriff (PDF)

Salvage surgery with abdominoperineal excision of the rectum (APER) following loco-regional failure after chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA) and the impact on long-term outcomes: Results of ACT II

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3523-3523

2016

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Radiotherapy
(7)
Hematology, Oncology And Palliative Medicine
(5)
Rectal Neoplasms - Radiotherapy
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Cancer
(4)
Chemoradiotherapy
(4)
Radiation Therapy
(4)
Rectal Cancer
(4)
Rectal Neoplasms - Drug Therapy
(4)
Rectal Neoplasms - Surgery
(4)
Surgery
(4)
Chemotherapy
(3)
Clinical Trials
(3)
Male
(3)
Medical Research
(3)
Patients
(3)
Prognosis
(3)
Rectal Neoplasms
(3)
Rectal Neoplasms - Pathology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial

Prognostic factors for patients with anal cancer treated with conformal radiotherapy-a systematic review

Choice of a patient-reported outcome measure for patients with anal cancer for use in cancer clinical trials and routine clinical practice: a mixed methods approach

Prognostic factors for recurrence and survival in anal cancer

Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer – A multicentre dose planning study

Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes

Treatment of T4 tumours: the role of radiotherapy

Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictors

1294: A Multi-Omics Database Using Clinical Trial Data for Rectal Cancer Radiotherapy Outcome Prediction

1317: Identifying Lymphocyte Infiltration for Rectal Cancer Outcome Prediction Using Phase III Trial Data

STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?

Can we S ave the rectum by watchful waiting or T rans A nal microsurgery following (chemo) R adiotherapy versus T otal mesorectal excision for early RE ctal C ancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study

“Global Multidisciplinary Team Meetings”: Challenging Cases Virtual Forums from the International Multidisciplinary Anal Cancer Conference (IMACC)

Abstract LB129: Stratification of radiotherapy and fluoropyrimidine-based chemotherapy from multi-omic profiling in rectal cancer biopsies

Radiotherapy for rectal cancer: Short course versus long course – When and how

153 - CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC)

CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC)

SPARC: A phase-I trial of pre-operative margin-intensified stereotactic radiotherapy for pancreatic cancer at high risk of positive resection margins

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC)

Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial

Radical surgery versus organ preservation for early-stage rectal cancer – Authors' reply

Short-course radiotherapy followed by neo-adjuvant chemotherapy in rectal cancer with synchronous liver metastases: A single institution experience

Is there a role for palliative pelvic radiotherapy in pelvic symptom control in metastatic/unresectable rectal cancer?

Aktive Filter

Suchergebnisse filtern